1. Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study

   • B. Saletu
   • E. Paulus
   • I. Podreka

   Original Investigation Pages: 385 - 395

2. Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice

   • T. Morita
   • S. Hitomi
   • H. Kuribara

   Original Investigation Pages: 396 - 402

3. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D₁ dopamine agonists in rodent and primate models of parkinson's disease — the differential effects of D₁ dopamine antagonists in the primate

   • Kanna K. Gnanalingham
   • Peter Jenner
   • C. David Marsden

   Original Investigation Pages: 403 - 412

4. The effect of carbamazepine on the 2-hydroxylation of desipramine

   • E. Spina
   • A. Avenoso
   • E. Perucca

   Original Investigation Pages: 413 - 416

5. A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia

   • D. C. Goff
   • E. Amico
   • J. W. Hubbard

   Original Investigation Pages: 417 - 423

6. Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome

   • E. Schweizer
   • W. G. Case
   • D. J. Greenblatt

   Original Investigation Pages: 424 - 429

7. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats

   • I. P. Stolerman
   • H. S. Garcha
   • N. R. Mirza

   Original Investigation Pages: 430 - 437

8. Long-term administration of butoctamide hydrogen succinate on nocturnal sleep of mentally retarded subjects: a polygraphic study versus placebo

   • G. L. Gigli
   • M. C. E. Maschio
   • P. Bergonzi

   Original Investigation Pages: 438 - 442

9. The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment

   • A. Badiani
   • S. G. Anagnostaras
   • T. E. Robinson

   Original Investigation Pages: 443 - 452

10. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine

    • S. Monleon
    • A. Parra
    • Paul Willner

    Original Investigation Pages: 453 - 457

11. 5-HT₃ agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration

    • G. R. King
    • Z. Xue
    • E. H. Ellinwood Jr.

    Original Investigation Pages: 458 - 465

12. Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder

    • C. A. Morgan III
    • C. Grillon
    • D. S. Charney

    Original Investigation Pages: 466 - 471

13. The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients

    • G. Gründer
    • H. Wetzel
    • O. Benkert

    Original Investigation Pages: 472 - 478

14. Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure

    • D. M. Tomkins
    • A. D. Le
    • E. M. Sellers

    Original Investigation Pages: 479 - 485

15. Effects of nitrous oxide on psychological performance. A dose-response study using inhalation of concentrations up to 15%

    • P. J. Armstrong
    • C. Morton
    • B. Tiplady

    Original Investigation Pages: 486 - 490